Main > ONCOLOGY (**) > Multiple Myeloma*** > Treatment > Co: JP. T. Ixazomib Cap.+



Co: JP. T. Ixazomib Cap.+'s subsections
(*) CA Approval Date: 2016. 08.08.
(*) USA Approval Date: 2015. 11.20
+Lenalidomide+Dexamethasone
Company
Mechanism: Proteasome Inhibitor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 14
Patent>UpDate: 2016. 09.20.
TradeMark
TradeMark Web-Site

Co: JP. T. Ixazomib Cap.+'s products
This section has no products